Back
Ryanair Holdings PLC Vs. Summit Therapeutics Industry Stock Comparison
Sell
47
RYAAY
Ryanair Holdings PLC
Last Price:
45.70
Seasonality Move:
11.81%
Buy
65
SMMT
Summit Therapeutics
Last Price:
21.41
Seasonality Move:
43.75%
Sell
47
Ryanair Holdings PLC (RYAAY)
is a Sell
Is Ryanair Holdings PLC a Buy, Sell or Hold?
- The current Ryanair Holdings PLC [RYAAY] share price is $45.68. The Score for RYAAY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RYAAY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $21.41. The Score for SMMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYAAY Stock Price Chart
What is Ryanair Holdings PLC's stock price today?
-
The Ryanair Holdings PLC share price today is $45.68
The current trend is moderately bullish and RYAAY is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $21.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
RYAAY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.46 | Buy |
Relative Strength Index (14 RSI): | 53.03 | Buy |
Chaikin Money Flow: | -1456657 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.6 - 45.82) | Buy |
Bollinger Bands (100): | (41.39 - 46.61) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 54.59 | Buy |
Chaikin Money Flow: | 421167 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.05 - 21.57) | Buy |
Bollinger Bands (100): | (9.09 - 21.39) | Buy |
RYAAY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.49 | Buy |
20-day SMA: | 45.1 | Buy |
50-day SMA: | 44.7 | Buy |
200-day SMA: | 49.1 | Sell |
8-day EMA: | 45.71 | Sell |
20-day EMA: | 45.19 | Buy |
50-day EMA: | 44.69 | Buy |
200-day EMA: | 46.1 | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20 | Buy |
20-day SMA: | 20.63 | Buy |
50-day SMA: | 20.55 | Buy |
200-day SMA: | 9.96 | Buy |
8-day EMA: | 20.63 | Buy |
20-day EMA: | 20.49 | Buy |
50-day EMA: | 19.23 | Buy |
200-day EMA: | 11.98 | Buy |
Ryanair Holdings PLC Earnings Growth & RYAAY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.00 per share, and a decrease next year of $0.62 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.08 per share.
Ryanair Holdings PLC Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |